OBJECTIVE -The purpose of this study was to compare the accuracy of measurements of glucose in interstitial fluid made with the FreeStyle Navigator Continuous Glucose Monitoring System with Yellow Springs Instrument laboratory reference measurements of venous blood glucose.RESEARCH DESIGN AND METHODS -Fifty-eight subjects with type 1 diabetes, aged 18 -64 years, were enrolled in a multicenter, prospective, single-arm study. Each subject wore two sensors simultaneously, which were calibrated with capillary fingerstick measurements at 10, 12, 24, and 72 h after insertion. Measurements from the FreeStyle Navigator system were collected at 1-min intervals and compared with venous measurements taken once every 15 min for 50 h over the 5-day period of sensor wear in an in-patient clinical research center. Periods of high rates of change of glucose were induced by insulin and glucose challenges. RESULTS -Comparison of the FreeStyle Navigator measurements with the laboratory ref-erence method (n ϭ 20,362) gave mean and median absolute relative differences (ARDs) of 12.8 and 9.3%, respectively. The percentage in the clinically accurate Clarke error grid A zone was 81.7% and that in the in the benign error B zone was 16.7%. During low rates of change (ϽϮ1 mg ⅐ dl Ϫ1 ⅐ min Ϫ1 ), the percentage in the A zone was higher (84.9%) and the mean and median ARDs were lower (11.7 and 8.5%, respectively).CONCLUSIONS -Measurements with the FreeStyle Navigator system were found to be consistent and accurate compared with venous measurements made using a laboratory reference method over 5 days of sensor wear (82.5% in the A zone on day 1 and 80.9% on day 5).
Background The effect of exercise induced hypoxaemia in determining submaximal exercise capacity, perceived breathlessness, and perceived exertion is not known. The purpose of this study was to investigate the relation of these variables to the results of lung function tests and the degree of hypoxaemia during submaximal exercise in patients with airflow limitation. Methods Forty two patients with chronic obstructive airways disease and 28 patients with chronic severe asthma were studied. Spirometry was performed and gas transfer (TLCO) and lung volumes were measured. Submaximal exercise capacity was assessed with a standardised six minute walk test. Arterial oxygen desaturation during the walk test was monitored by a portable pulse oximeter. Patients rated their perceived degree of respiratory impairment on a Medical Research Council (MRC) breathlessness scale before the walk. Perceived breathlessness was measured by means of a linear visual analogue scale and exertion on the Borg scale after the walk. Results The six minute walk distance was strongly correlated (r value) with TLCO (0-68), peak expiratory flow (PEF: 0-55), forced expiratory volume in one second (FEV,: 0 53), transfer coefficient Kco: 0 49), age (-0 49), and forced vital capacity (FVC: 0 48) but not with oxygen desaturation during the walk. Walk distance was also correlated with the breathlessness rating on the MRC scale (-0 52), but less strongly with perceived breathlessness (-0 35) and perceived exertion (-0'30). The prediction equation for the six minute walk distance in metres (6MD) generated by multiple regression analysis was 6MD = 387 + 29-7 (TLCO) -3-1(age) + 0-35(PEF l/min), which accounted for 50% of the total variance in walk distance. Conclusions Oxygen desaturation during the six minute walk is not related to walk distance, nor does it determine the degree of perceived exertion or perceived breathlessness in patients with airflow limitation. Patients who consider themselves the most disabled by breathlessness have the shortest six minute walk distance but do not necessarily have appreciable desaturation. (Thorax 1993;48:33-38) Among the most common symptoms in patients with respiratory diseases are breathlessness, reduced exercise capacity, and an increase in the sensation of effort taken to perform everyday tasks. Arterial oxygen desaturation is known to occur during exercise in some patients with respiratory disease.'7 A possible explanation for these symptoms could be arterial hypoxaemia leading to reduced oxygen delivery and acidosis resulting from anaerobic respiration; but the role of exercise induced hypoxaemia in determining submaximal exercise capacity and the degree of perceived breathlessness and perceived exertion in patients with respiratory disease is uncertain. No study has specifically examined the relation of hypoxaemia occurring during submaximal exercise to the submaximal exercise capacity and the degree of perceived breathlessness and perceived exertion.Most studies investigating exercise induced hypo...
Objective-To examine the quantitative relation between exposure to isocyanates and occupational asthma, and to explore the role of atopy and smoking in occurrence of the disease. Method-A case-referent study was undertaken of cases from two manufacturing companies (A and B) from which referents without disease could be selected and reliable exposure measurements were available. In company A, 27 cases mainly attributed to toluene diisocyanate (TDI) were matched to 51 referents on work area, start and duration of employment, sex, and age. Exposures were estimated from existing measurements by job category. In company B there were seven cases attributed to 4,4'-diphenylmethane diisocyanate (MDI) in two areas of the plant; 12 non-cases from the same areas were used as referents. Personal exposure measurements were available for all cases and 11 referents. Results-No diVerence in peak exposures between cases and referents was found in either plant; but in both, time weighted average (TWA) exposures at the time of onset of asthma were higher for cases. In A, the mean TWA exposure for cases was 1.5 (95% confidence interval (95% CI) 1.2 to 1.8) ppb compared with 1.2 (1.0 to 1.4) ppb for referents. From a matched analysis, the odds ratio (OR) associated with 8 hour TWA exposure to isocyanates greater than 1.125 ppb (the median concentration for the referent group) was 3.2 (95% CI 0.96 to 10.6; p=0.06). Occupational asthma was associated with a pre-employment history of atopic illness (OR 3.5, p=0.04) and, less strongly, with smoking (OR 2.1, p=0.14). In B, small numbers limited analysis, but three of seven cases had at least one TWA exposure measurement greater than 5 ppb compared with one of 11 referents (OR 7.5, p=0.09). Conclusion-Asthma can occur at low concentrations of isocyanates, but even at low concentrations, the higher the exposure the greater the risk. By contrast with other studies, smoking and atopy seemed to increase the odds of occupational asthma due to isocyanates, but did not aVect the estimate of risk associated with exposure. (Occup Environ Med 2000;57:830-836)
Aims/hypothesis This study was designed to investigate the use and impact of a continuous glucose monitoring system (the FreeStyle Navigator) under home-use conditions in the self-management of type 1 diabetes. Methods A 20 day masked phase, when real-time data and alarms were not available, was compared with a subsequent 40 day unmasked phase for a number of specified measures of glycaemic variability. HbA 1c (measured by DCA 2000) and a hypoglycaemia fear survey were recorded at the start and end of the study. Results The study included 48 patients with type 1 diabetes (mean age 35.7±10.9, range 18-61 years; diabetes duration 17.0±9.5 years). Two patients did not complete the study for personal reasons. Comparing masked (all 20 days) and unmasked (last 20 days) phases, the following reductions were seen: time outside euglycaemia from 11.0 to 9.5 h/day (p=0.002); glucose SD from 3.5 to 3.2 mmol/l (p<0.001); hyperglycaemic time (>10.0 mmol/l) from 10.3 to 8.9 h/day (p=0.0035); mean amplitude of glycaemic excursions (peak to nadir) down by 10% (p<0.001); high blood glucose index down by 18% (p=0.0014); and glycaemic risk assessment diabetes equation score down by 12% (p= 0.0013). Hypoglycaemic time (<3.9 mmol/l) decreased from 0.70 to 0
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.